Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk

BACKGROUND: MetaboHealth represents a novel indicator of overall health in middle age and may potentially be suitable as actionable health check in prevention strategies. MetaboHealth is a blood-based metabolomic composite score that predicts a wide range of age-related conditions and mortality in large European cohorts. METHODS: Here, we investigated whether MetaboHealth can be personalised and limited to clinically validated, i.e. CE-marked, metabolic biomarkers. Next, we assessed whether the updated MetaboHealth score predicts all-cause mortality and cardiometabolic disease incidence and can be improved by a lifestyle intervention. To personalise MetaboHealth, we scaled the metabolic biomarkers using a Dutch reference population (i.e. the Biobanking and BioMolecular Research Infrastructure Netherlands) and, in addition, based the score solely on clinically validated metabolic biomarkers. RESULTS: The novel version of the score, Personal-MetaboHealth, retained predictive accuracy for all-cause mortality and showed an even stronger association with incident cardiometabolic disease in the Leiden Longevity Study (LLS) in which 2,404 participants were followed for up to 22 and 16 years for mortality and morbidity, respectively. The association of Personal-MetaboHealth with all-cause mortality remained robust after adjusting for smoking quantity, alcohol consumption, and medication use, while the cardiometabolic disease association was attenuated due to smoking quantity. Each unit increase in Personal-MetaboHealth was associated with a 13.69 year later onset of the first cardiometabolic disease in the LLS. Next, we showed that Personal-MetaboHealth can be improved by a 3-month combined lifestyle intervention in middle aged individuals (Growing Old Together study), specifically in those at risk, i.e. with an unhealthy score at baseline. CONCLUSIONS: Personal-MetaboHealth thus offers a potential actionable health check in middle age for early prevention and extension of healthy lifespan.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-09-06
DOI
https://doi.org/10.1186/s12916-026-05178-z
Citations
1
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
2.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk

Fatih A. Bogaards, Joris Deelen, P. Eline Slagboom, Niels van den Berg et al.
1 citations
BMC Medicine
Metabolomics and Mass Spectrometry Studies
2.84
article

Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk

Fatih A. Bogaards, Joris Deelen, P. Eline Slagboom, Niels van den Berg, Marian Beekman, Gabriela Natalle Lopes, Edson Amaro Junior
article en
1 citations

Abstract

BACKGROUND: MetaboHealth represents a novel indicator of overall health in middle age and may potentially be suitable as actionable health check in prevention strategies. MetaboHealth is a blood-based metabolomic composite score that predicts a wide range of age-related conditions and mortality in large European cohorts. METHODS: Here, we investigated whether MetaboHealth can be personalised and limited to clinically validated, i.e. CE-marked, metabolic biomarkers. Next, we assessed whether the updated MetaboHealth score predicts all-cause mortality and cardiometabolic disease incidence and can be improved by a lifestyle intervention. To personalise MetaboHealth, we scaled the metabolic biomarkers using a Dutch reference population (i.e. the Biobanking and BioMolecular Research Infrastructure Netherlands) and, in addition, based the score solely on clinically validated metabolic biomarkers. RESULTS: The novel version of the score, Personal-MetaboHealth, retained predictive accuracy for all-cause mortality and showed an even stronger association with incident cardiometabolic disease in the Leiden Longevity Study (LLS) in which 2,404 participants were followed for up to 22 and 16 years for mortality and morbidity, respectively. The association of Personal-MetaboHealth with all-cause mortality remained robust after adjusting for smoking quantity, alcohol consumption, and medication use, while the cardiometabolic disease association was attenuated due to smoking quantity. Each unit increase in Personal-MetaboHealth was associated with a 13.69 year later onset of the first cardiometabolic disease in the LLS. Next, we showed that Personal-MetaboHealth can be improved by a 3-month combined lifestyle intervention in middle aged individuals (Growing Old Together study), specifically in those at risk, i.e. with an unhealthy score at baseline. CONCLUSIONS: Personal-MetaboHealth thus offers a potential actionable health check in middle age for early prevention and extension of healthy lifespan.

BMC MedicineVol. 24(1)
Leiden University (NL), Leiden University Medical Center (NL), Hospital Israelita Albert Einstein (BR), The Hague University of Applied Sciences (NL)
European Commission, Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Openalex Percentile: Top 14%
Metabolomics and Mass Spectrometry Studies
2.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.